Intravitreal bevacizumab in treatment of idiopathic persistent central serous chorioretinopathy: a prospective, controlled clinical study

Current Eye Research
Ozgur ArtunayHalil Bahcecioglu

Abstract

To evaluate and determine the effect of intravitreal bevacizumab in treatment of persistent central serous chorioretinopathy. This prospective, comparative clinical study included 30 eyes of 30 patients with persistent, symptomatic central serous chorioretinopathy of 3 months' duration or more. Fifteen eyes of 15 patients were treated with intravitreal injections of 2.5 mg (0.1 ml) bevacizumab (treatment group). Fifteen eyes of 15 patients with the same characteristics who declined treatment were an acceptable control group. The visual and anatomic responses were observed with best-corrected visual acuity and central foveal thickness measured by optic coherence tomography at baseline,1, 3, and 6 months after treatment. Twelve (80%) eyes in the treatment group compared with 8 (53.3%) eyes in the control group showed morphologic restitution at 6 months (P < 0.01). All 15 (100%) treated eyes had stable or improved vision, compared with 10 (66.6%) eyes in the control group (P < 0.01). At 6 months, the mean +/- SD central foveal thickness for the treatment group remained significantly lower compared to the control group, with 174 +/- 68 microm and 297 +/- 172 microm, respectively (P < 0.001). Injection-related complications were not...Continue Reading

References

Jan 1, 1992·Documenta Ophthalmologica. Advances in Ophthalmology·J Castro-CorreiaJ Maia
Jan 1, 1988·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·M F Marmor
Jan 1, 1986·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·M Spitznas
Jan 1, 1982·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·H YoshiokaH Akune
Aug 1, 1994·Archives of Ophthalmology·D R GuyerD Orlock
Jun 1, 1993·The British Journal of Ophthalmology·D IeM J Daily
Jan 1, 1996·American Journal of Ophthalmology·C Prünte, J Flammer
May 31, 2002·American Journal of Ophthalmology·Andrea von RückmannAlan C Bird
Apr 23, 2003·Retina·M Battaglia ParodiG Ravalico
Jan 7, 2004·Retina·Felice Cardillo PiccolinoFederico M Grignolo
Jun 9, 2004·American Journal of Ophthalmology·Mehryar TabanMehran Taban
Mar 1, 2005·American Journal of Ophthalmology·Raj Vardhan AzadYog Raj Sharma
Aug 2, 2006·Acta Ophthalmologica Scandinavica·Ulrich H M SpandauJost B Jonas
Dec 21, 2006·The British Journal of Ophthalmology·Swaantje PetersKarl-Ulrich Bartz-Schmidt
Apr 24, 2007·American Journal of Ophthalmology·Swaantje PetersUlrich Schraermeyer
Jul 31, 2007·Acta Ophthalmologica·Maria WangMichael Larsen
Sep 25, 2007·Retina·Catherine B MeyerleLawrence A Yannuzzi
Jun 5, 2008·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Mitzy E Torres-SorianoHugo Quiroz-Mercado

❮ Previous
Next ❯

Citations

Nov 18, 2011·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·M MaierC P Lohmann
Sep 29, 2011·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·M Töteberg-HarmsR Windisch
Oct 12, 2012·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·I BegerF Koch
Dec 9, 2010·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Ji Won Lim, Min Uk Kim
Aug 18, 2010·Clinical Ophthalmology·Antonio CaccavaleFabio Ferentini
Feb 11, 2014·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·M MaierC P Lohmann
Sep 13, 2014·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Ahmet AltunTugba Gencaga Atakan
Jul 16, 2013·Cutaneous and Ocular Toxicology·Ozdemir Ozdemir, Muhammet Kazim Erol
Feb 16, 2013·Survey of Ophthalmology·Benjamin NicholsonCatherine Meyerle
Jul 14, 2012·Clinical & Experimental Ophthalmology·Godfrey QuinSamantha Fraser-Bell
Jul 14, 2012·Clinical & Experimental Ophthalmology·Gerald LiewSamantha Fraser-Bell
Jul 15, 2015·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Majid AbrishamiAmir Norouzpour
Feb 27, 2015·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Ju Young KimSi Yeol Kim
Jun 1, 2015·Progress in Retinal and Eye Research·Alejandra DaruichFrancine Behar-Cohen
May 20, 2016·Journal of Ophthalmic & Vision Research·Cihan ÜnlüTahir Kansu Bozkurt
Aug 31, 2016·International Ophthalmology Clinics·Nisreen S EzuddinChristina Y Weng
Sep 1, 2012·Asia-Pacific Journal of Ophthalmology·David T LiuDennis S C Lam
Apr 8, 2017·International Journal of Clinical Pharmacy·Shangli JiShibo Tang
Jan 25, 2019·Current Pharmaceutical Design·Pierluigi IaconoMaria Cristina Parravano
Mar 24, 2011·Current Opinion in Ophthalmology·Alexander RossQuresh Mohamed
Jul 17, 2020·International Ophthalmology·Umut DağMehmet Fuat Alakuş
Aug 29, 2020·Case Reports in Ophthalmological Medicine·Prashanth G IyerHarry W Flynn
Sep 27, 2020·Pharmaceuticals·Massimo NicolòCarlo Enrico Traverso
Jul 19, 2019·Progress in Retinal and Eye Research·Thomas J van RijssenCamiel J F Boon
Dec 24, 2020·The British Journal of Ophthalmology·David XuDavid Sarraf
Apr 17, 2021·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·Laurenz PauleikhoffClemens Lange
Sep 7, 2020·Archivos de la Sociedad Española de Oftalmología·F J Moreno-MorilloJ Donate-López

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.